FDA Warning Letter — Contacare Ophthalmics & Diagnostics
The FDA took a Warning Letter action against Contacare Ophthalmics & Diagnostics on April 23, 2019 (Dabhasa, India). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Contacare Ophthalmics & Diagnostics
- Date
- April 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Dabhasa (India)